NMTRX | VWALX | NMTRX / VWALX | |
Total Expense Ratio | 0.00 | 0.09 | - |
Annual Report Gross Expense Ratio | 0.07 | 0.09 | 78% |
Fund Existence | 18 years | 23 years | - |
Gain YTD | -1.804 | -2.961 | 61% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 50000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.55B | 16.2B | 10% |
Annual Yield % from dividends | 4.38 | 3.92 | 112% |
Returns for 1 year | 1.47 | -1.67 | -88% |
Returns for 3 years | 5.37 | -2.95 | -182% |
Returns for 5 years | 5.34 | -5.60 | -95% |
Returns for 10 years | 26.92 | -7.20 | -374% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JDWRX | 108.34 | 0.42 | +0.39% |
Janus Henderson Global Research R | |||
RWMHX | 60.55 | 0.23 | +0.38% |
American Funds Washington Mutual R5E | |||
RCGHX | 15.36 | N/A | N/A |
Virtus KAR Health Sciences C | |||
HRSCX | 18.15 | N/A | N/A |
Carillon Eagle Small Cap Growth A | |||
CSHNX | 11.25 | -0.05 | -0.44% |
NYLI Cushing® MLP Premier Investor Class |